BACKGROUND: Abdominal and thoracic aortic aneurysms are diagnosed in 40 and 10 to 15 out of 100 000 persons per year, respectively. Fenestrated (fEVAR) and branched (bEVAR) stent grafts have been developed for abdominal juxtarenal and thoracoabdominal aneurysms. We discuss the patency and complication rates of fEVAR and bEVAR procedures and compare them with the outcome of open surgery. METHODS: This review is based on pertinent publications from 2011 to 2014 that were retrieved by a selective literature search. The clinical outcomes of case series involving a total of more than 1500 patients are presented. The discussion takes account of recommendations contained in the literature and the authors' own experience. RESULTS: Open surgery and aortic stent grafting have not been compared in any randomized trial to date. We identified 7 clinical series that included a total of 1270 fEVAR patients and 5 with a total of 408 bEVAR patients. The perioperative mortality after fEVAR procedures was 0-4%. Spinal cord ischemia arose in 1% of cases. The stent patency rate in visceral vessels ranged from 93 to 98%. bEVAR procedures were associated with both higher mortality (4-7%) and more common spinal cord ischemia (4-13%). 5-8% of all patients needed dialysis perioperatively, and the stent patency rate in visceral vessels was 94-97%. Preoperative renal insufficiency was a risk factor for peri-interventional death. Impaired renal function after fEVAR/bEVAR procedures was mainly associated with intermittent lower limb ischemia. CONCLUSION: The results of fEVAR/bEVAR procedures in the last 5 years are similar to those of open surgery. The high postoperative rate of spinal cord ischemia remains a serious problem in the endovascular treatment of thoracoabdominal aortic aneurysms. The decision to implant a stent graft by an endovascular approach or to treat surgically should be made on a case-to-case basis in an interdisciplinary vascular conference.
BACKGROUND: Abdominal and thoracic aortic aneurysms are diagnosed in 40 and 10 to 15 out of 100 000 persons per year, respectively. Fenestrated (fEVAR) and branched (bEVAR) stent grafts have been developed for abdominal juxtarenal and thoracoabdominal aneurysms. We discuss the patency and complication rates of fEVAR and bEVAR procedures and compare them with the outcome of open surgery. METHODS: This review is based on pertinent publications from 2011 to 2014 that were retrieved by a selective literature search. The clinical outcomes of case series involving a total of more than 1500 patients are presented. The discussion takes account of recommendations contained in the literature and the authors' own experience. RESULTS: Open surgery and aortic stent grafting have not been compared in any randomized trial to date. We identified 7 clinical series that included a total of 1270 fEVAR patients and 5 with a total of 408 bEVAR patients. The perioperative mortality after fEVAR procedures was 0-4%. Spinal cord ischemia arose in 1% of cases. The stent patency rate in visceral vessels ranged from 93 to 98%. bEVAR procedures were associated with both higher mortality (4-7%) and more common spinal cord ischemia (4-13%). 5-8% of all patients needed dialysis perioperatively, and the stent patency rate in visceral vessels was 94-97%. Preoperative renal insufficiency was a risk factor for peri-interventional death. Impaired renal function after fEVAR/bEVAR procedures was mainly associated with intermittent lower limb ischemia. CONCLUSION: The results of fEVAR/bEVAR procedures in the last 5 years are similar to those of open surgery. The high postoperative rate of spinal cord ischemia remains a serious problem in the endovascular treatment of thoracoabdominal aortic aneurysms. The decision to implant a stent graft by an endovascular approach or to treat surgically should be made on a case-to-case basis in an interdisciplinary vascular conference.
Authors: Raimund Erbel; Victor Aboyans; Catherine Boileau; Eduardo Bossone; Roberto Di Bartolomeo; Holger Eggebrecht; Arturo Evangelista; Volkmar Falk; Herbert Frank; Oliver Gaemperli; Martin Grabenwöger; Axel Haverich; Bernard Iung; Athanasios John Manolis; Folkert Meijboom; Christoph A Nienaber; Marco Roffi; Hervé Rousseau; Udo Sechtem; Per Anton Sirnes; Regula S von Allmen; Christiaan J M Vrints Journal: Eur Heart J Date: 2014-08-29 Impact factor: 29.983
Authors: Natalia O Glebova; Shalini Selvarajah; Kristine C Orion; James H Black; Mahmoud B Malas; Bruce A Perler; Christopher J Abularrage Journal: J Vasc Surg Date: 2014-12-09 Impact factor: 4.268
Authors: H J Pleumeekers; A W Hoes; E van der Does; H van Urk; A Hofman; P T de Jong; D E Grobbee Journal: Am J Epidemiol Date: 1995-12-15 Impact factor: 4.897
Authors: Ian M Nordon; Robert J Hinchliffe; Peter J Holt; Rob Morgan; Marjan Jahangiri; Ian M Loftus; Matt M Thompson Journal: J Vasc Surg Date: 2009-07-26 Impact factor: 4.268
Authors: Gustavo S Oderich; Roy K Greenberg; Mark Farber; Sean Lyden; Luis Sanchez; Ron Fairman; Feiyi Jia; Priya Bharadwaj Journal: J Vasc Surg Date: 2014-09-05 Impact factor: 4.268
Authors: Abdullah O Alenezi; Elizabeth Tai; Arash Jaberi; Andrew Brown; Sebastian Mafeld; Graham Roche-Nagle Journal: Cardiovasc Intervent Radiol Date: 2021-01-03 Impact factor: 2.740
Authors: Sven R Hauck; Alexander Kupferthaler; Martin C Freund; Peter Pichler; Marie-Elisabeth Stelzmüller; Christopher Burghuber; Marek Ehrlich; Harald Teufelsbauer; Christian Loewe; Martin A Funovics Journal: Insights Imaging Date: 2022-03-28
Authors: Sven R Hauck; Wolf Eilenberg; Alexander Kupferthaler; Maximilian Kern; Theresa-Marie Dachs; Alexander Wressnegger; Christoph Neumayer; Christian Loewe; Martin A Funovics Journal: Cardiovasc Intervent Radiol Date: 2022-04-07 Impact factor: 2.797